Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

The Synthesis of Parasitic Cysteine Protease and Trypanothione Reductase Inhibitors

Author(s): Kelly Chibale and Chitalu C. Musonda

Volume 10 , Issue 18 , 2003

Page: [1863 - 1889] Pages: 27

DOI: 10.2174/0929867033456963

Price: $65

Abstract

The presence of parasitic cysteine proteases and trypanothione reductase in the parasitic protozoa of the genus Trypanosoma and Leishmania has made these enzymes attractive targets for the development of antitrypanosomal and antileishmanial agents. Furthermore, the presence of cysteine proteases in Plasmodium falciparum has presented additional opportunities for the development of chemical scaffolds that could potentially be utilized against all of the aforementioned parasites. While previous reviews on parasitic cysteine proteases and trypanothione reductase covered various aspects, none emphasized the chemistry behind the synthesis of described inhibitors. This review focuses on recent developments in the synthesis of low- molecular weight inhibitors of these enzymes with a bearing on the human diseases of leishmaniasis, malaria and trypanosomiasis. Only those inhibitors whose synthesis has been described in the open literature during the period 1993-mid 2002 have been highlighted. The review thus excludes what may be in the patent literature. Inhibitors synthesized using combinatorial and / or parallel synthesis chemistry as well as polymer-assisted synthesis methodologies have been deliberately omitted from this review because they are a subject of a separate and focused review.

Keywords: cruzain, falcipain-2, rhodesain, trypanothione reductase, inhibitors and synthesis


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy